Forxiga Faces Tough Rival
![EU Approves Jardiance for CKD: Forxiga Faces Tough Rival](https://pharmtales.com/wp-content/uploads/2023/07/Jardiance-Receives-EU-Approval-for-Treating-Chronic-Kidney-Disease-CKD-Posing-a-Strong-Challenge-to-Forxiga.jpg)
Jardiance Receives EU Approval for Treating Chronic Kidney Disease (CKD), Posing a Strong Challenge to Forxiga
SG Tylor
Source – Boehringer Ingelheim The European Union has granted approval for Boehringer Ingelheim and Eli Lilly’s SGLT2 inhibitor, Jardiance (empagliflozin), ...